Wolverine Asset Management LLC Johnson & Johnson Put Options Transaction History

Wolverine Asset Management LLC

$4.35 Billion
Q3 2024

Put Options

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 04, 2024	BUY	$145.48 - $167.38 $4.5 Million - $5.17 Million	30,900 Added 40.71%	106,800 $17.3 Million
Q2 2024 Aug 01, 2024	BUY	$144.38 - $157.78 $2.67 Million - $2.92 Million	18,500 Added 32.23%	75,900 $11.1 Million
Q1 2024 May 13, 2024	SELL	$155.22 - $162.74 $10.6 Million - $11.1 Million	-68,100 Reduced 54.26%	57,400 $9.08 Million
Q4 2023 Feb 01, 2024	SELL	$145.6 - $158.88 $5.98 Million - $6.53 Million	-41,100 Reduced 24.67%	125,500 $19.7 Million
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $4.72 Million - $5.29 Million	30,300 Added 22.23%	166,600 $25.9 Million
Q2 2023 Aug 07, 2023	BUY	$154.35 - $166.11 $4.29 Million - $4.62 Million	27,800 Added 25.62%	136,300 $22.6 Million
Q1 2023 May 08, 2023	BUY	$151.05 - $180.26 $4.8 Million - $5.73 Million	31,800 Added 41.46%	108,500 $16.8 Million
Q4 2022 Feb 01, 2023	SELL	$160.2 - $179.79 $11.7 Million - $13.2 Million	-73,200 Reduced 48.83%	76,700 $13.5 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $11.8 Million - $13.1 Million	73,200 Added 95.44%	149,900 $24.5 Million
Q2 2022 Aug 03, 2022	BUY	$168.19 - $186.01 $8.41 Million - $9.3 Million	50,000 Added 187.27%	76,700 $13.6 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $1.22 Million - $1.34 Million	9,300 Added 53.45%	26,700 $3.72 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $6.5 Million - $7.23 Million	-51,700 Reduced 74.82%	17,400 $2.43 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $4.2 Million - $5.06 Million	-34,200 Reduced 33.11%	69,100 $8.92 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $12.3 Million - $13.6 Million	103,300 New	103,300 $12.5 Million

Others Institutions Holding JNJ

# of Institutions

4,227

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.

Account